B+
Bull case
25%
Probability
Target price
$220.00
+22.3% vs current
MOH
Molina HealthcareBNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
50%
Probability
Target price
$166.64
-7.4% vs current
B-
Bear case
25%
Probability
Target price
$120.00
-33.3% vs current
AI sentiment snapshot
Latest data as of 2026-04-10
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+42.3
Score
AI commentary
Market tone is cautious after management affirmed 2026 outlook in an 8‑K and filed the 10‑K, while news coverage flagged guidance below some Street estimates—investor focus is on execution vs. that guidance and margin headwinds [#8-K-2026-02-26] [#10-K-2026-02-10]. Short-term sentiment is mixed-to-negative; longer-term views hinge on FY2026 operating delivery and state-program outcomes [#SERP-1].
RankAlpha Sentiment AI - 2026-04-10
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-07-10catalystQuarterly earnings / call reaction to 2026 margin headwindsHigh impact
Near-term quarterly releases and management commentary can trigger >10% moves if 2026 cost pressures cited by management persist; SEC filings and investor materials flagged an affirmed 2026 outlook and investor-day cadence to discuss guidance [#8-K-2026-02-26] [#10-K-2026-02-10].
2026-12-31eventMarket monitors full-year 2026 execution vs. management's affirmed 2026 outlookHigh impact
Management affirmed the 2026 outlook in an 8-K filed 2026-02-26; investors will re-rate the stock against realized premium revenue and adjusted earnings for FY2026 as results and state-by-state MLR developments are reported through year-end [#8-K-2026-02-26].
2027-02-10catalystFY2026 guidance / operating drivers crystallize (premium revenue and margin execution)High impact
Molina's 10-K and related disclosures provide the baseline for FY2026 operating targets; material upside requires premium revenue growth and managed care margin stability versus the guidance window disclosed in filings [#10-K-2026-02-10] (monitor state-program trends, medical cost ratio, and reserve development through FY2026).
Recommendation
N/A
No formal recommendation provided.
As of 2026-04-10 • Updated nightlySource: Internal modelMethodology